← Back to Analyst Consensus 
ANAB Buy
ANAPTYSBIO, INC
Current Price —
Implied Upside —
Analysts 15
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 10, 2026 (14 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 30, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Sep 24, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Sep 23, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 51% |
| Aug 25, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Aug 24, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 13, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| May 13, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 4, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Apr 28, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 51% |
| Apr 22, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Apr 21, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Mar 31, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Mar 30, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 17, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Mar 12, 2026 | Wedbush | maintain | Outperform → Outperform | — | 57% |
| Mar 9, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Mar 5, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Mar 4, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Mar 4, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jan 20, 2026 | Barclays | maintain | Overweight → Overweight | $78 | 53% |
| Dec 17, 2025 | Barclays | maintain | Overweight → Overweight | $55 | 53% |
| Dec 11, 2025 | Stifel | maintain | Buy → Buy | $56 | 53% |
| Nov 24, 2025 | Wedbush | reiterate | Outperform → Outperform | $50 | 57% |
| Nov 24, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $51 | 44% |
| Nov 11, 2025 | Barclays | maintain | Overweight → Overweight | $70 | 53% |
| Nov 11, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $52 | 44% |
| Nov 10, 2025 | Truist Securities | maintain | Hold → Hold | $36 | 54% |
| Nov 5, 2025 | Guggenheim | maintain | Buy → Buy | $100 | 52% |
| Nov 5, 2025 | Wells Fargo | maintain | Overweight → Overweight | $81 | 54% |
| Oct 29, 2025 | Stifel | maintain | Buy → Buy | $80 | 53% |
| Oct 15, 2025 | Wedbush | maintain | Outperform → Outperform | $70 | 57% |
| Oct 13, 2025 | Barclays | initiate | — → Overweight | $78 | 53% |
| Sep 30, 2025 | Wedbush | reiterate | Outperform → Outperform | $45 | 57% |
| Sep 30, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $59 | 44% |
| Aug 12, 2025 | UBS | maintain | Neutral → Neutral | $20 | 54% |
| Aug 7, 2025 | Wedbush | maintain | Outperform → Outperform | $45 | 57% |
| Jul 24, 2025 | JP Morgan | maintain | Overweight → Overweight | $80 | 55% |
| Jun 4, 2025 | HC Wainwright & Co. | upgrade | Neutral → Buy | $38 | 44% |
| May 28, 2025 | Guggenheim | maintain | Buy → Buy | $90 | 52% |
| May 6, 2025 | Guggenheim | maintain | Buy → Buy | $54 | 52% |
| May 1, 2025 | Wedbush | reiterate | Outperform → Outperform | $40 | 57% |
| Mar 5, 2025 | JP Morgan | maintain | Overweight → Overweight | $42 | 55% |
| Mar 4, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $22 | 44% |
| Feb 13, 2025 | Wells Fargo | maintain | Overweight → Overweight | $51 | 54% |
| Feb 12, 2025 | HC Wainwright & Co. | maintain | Neutral → Neutral | $22 | 44% |
| Feb 7, 2025 | Wedbush | maintain | Outperform → Outperform | $40 | 57% |
| Feb 4, 2025 | Wolfe Research | initiate | — → Outperform | $0 | 54% |
| Feb 4, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $19 | 44% |
| Dec 19, 2024 | JP Morgan | maintain | Overweight → Overweight | $36 | 55% |
| Dec 18, 2024 | Truist Securities | maintain | Hold → Hold | $20 | 54% |
Price Target Trend
Jun 8, 2026 Oct 27, 2026
EPS Estimates
+1q —
0y —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days